Literature DB >> 18685378

Mechanisms to explain wasting of muscle and fat in cancer cachexia.

Josep M Argilés1, Francisco J López-Soriano, Sílvia Busquets.   

Abstract

PURPOSE OF REVIEW: To describe the most relevant recent findings concerning the molecular mechanisms involved in both fat and muscle tissues in cachectic cancer patients. RECENT
FINDINGS: Relevant progress has been made in the mechanism of signalling protein metabolism in skeletal muscle. PI3K has a dual role inhibiting protein degradation by inhibition of Atrogin-1 and MuRF1 gene expression and facilitating AKT phosphorylation, leading to increased protein synthesis. Interestingly, Caspase-3 activity is intimately associated with myofibrillar protein degradation in muscle tissue. With respect to fat metabolism, increased lipolysis in human cancer cachexia seems to be directly connected to increased hormone-sensitive lipase activity.
SUMMARY: The results and findings described in this review represent important progress in wasting disease mechanisms and may provide hints for future therapeutic approaches in cancer cachexia.

Entities:  

Mesh:

Year:  2007        PMID: 18685378     DOI: 10.1097/SPC.0b013e3282f34738

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  12 in total

Review 1.  Exercise rehabilitation in patients with cancer.

Authors:  Susan G Lakoski; Neil D Eves; Pamela S Douglas; Lee W Jones
Journal:  Nat Rev Clin Oncol       Date:  2012-03-06       Impact factor: 66.675

2.  Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Authors:  Jochen K Lennerz; Jonathan B Hurov; Lynn S White; Katherine T Lewandowski; Julie L Prior; G James Planer; Robert W Gereau; David Piwnica-Worms; Robert E Schmidt; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

Review 3.  Cancer cachexia: understanding the molecular basis.

Authors:  Josep M Argilés; Sílvia Busquets; Britta Stemmler; Francisco J López-Soriano
Journal:  Nat Rev Cancer       Date:  2014-10-09       Impact factor: 60.716

4.  Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.

Authors:  Mary G Rhoads; Susan C Kandarian; Fabio Pacelli; Giovan Battista Doglietto; Maurizio Bossola
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

5.  Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency.

Authors:  Cloé M Julienne; Jean-François Dumas; Caroline Goupille; Michelle Pinault; Cécile Berri; Anne Collin; Sophie Tesseraud; Charles Couet; Stephane Servais
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

6.  Optimal management of cancer anorexia-cachexia syndrome.

Authors:  Josep M Argilés; Mireia Olivan; Sílvia Busquets; Francisco Javier López-Soriano
Journal:  Cancer Manag Res       Date:  2010-01-22       Impact factor: 3.989

7.  Exercise interventions in children with cancer: a review.

Authors:  Tseng-Tien Huang; Kirsten K Ness
Journal:  Int J Pediatr       Date:  2011-10-27

8.  Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Authors:  Kenji Imai; Koji Takai; Takao Miwa; Daisuke Taguchi; Tatsunori Hanai; Atsushi Suetsugu; Makoto Shiraki; Masahito Shimizu
Journal:  Cancers (Basel)       Date:  2019-08-19       Impact factor: 6.639

Review 9.  The role of triglyceride lipases in cancer associated cachexia.

Authors:  Suman K Das; Gerald Hoefler
Journal:  Trends Mol Med       Date:  2013-03-14       Impact factor: 11.951

Review 10.  Nonmuscle Tissues Contribution to Cancer Cachexia.

Authors:  Josep M Argilés; Britta Stemmler; Francisco J López-Soriano; Silvia Busquets
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.